Survey the effect of Elaeagnus Angustifolia supplementation on the symptoms of primary dysmenorrhea in female students of Ahvaz Jundishapur university

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190603043807N1

Enrollment

Registered

2020-02-10

Start date

2020-02-19

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: Intervention group: Group receiving sachet 15 g. Each participant is monitored over 3 periods. During the first period (menstrual cycle), participants record the severity of dysmenorrh

Eligibility

Sex/Gender

Female

Age

18 Years to 26 Years

Inclusion criteria

Inclusion criteria: Single; Age 18-26 years; Literacy; Having regular menstrual period between 26-30 days Premenstrual syncope several hours ago; Menstrual pain less than 3 days primary menstrual pain in recent years Moderate to severe dysmenorrhea according to visual analogue scale (VAS) body mass index (BMI) = 18.5-24.9 kg / m2; duration of menstrual bleeding more than 7 days; No more than 14 healthbars consumed no known medical illness A special diet such as weight loss obesity No vegetarianism or water treatment no tobacco or alcohol use no regular exercise

Exclusion criteria

Exclusion criteria: Use of oral contraceptives or other steroid hormones so any genital tract disease, a history of any problems or kidney stones, any physical mental illness has been diagnosed

Design outcomes

Primary

Measure	Time frame
Intensity of pain. Timepoint: Before the beginning of intervention - the first and the second month after the intervention. Method of measurement: VISUAL ANALOG SCALE.;Duration of pain. Timepoint: Before the beginning of intervention - the first and the second month after the intervention. Method of measurement: Table of Specifications of Control and Tracking Cycles.;Duration of bleeding. Timepoint: Before the beginning of intervention - the first and the second month after the intervention. Method of measurement: Higam chart.;The severity of the bleeding. Timepoint: Before the beginning of intervention - the first and the second month after the intervention. Method of measurement: Higam chart.	—

Measure

Time frame

Intensity of pain. Timepoint: Before the beginning of intervention - the first and the second month after the intervention. Method of measurement: VISUAL ANALOG SCALE.;Duration of pain. Timepoint: Before the beginning of intervention - the first and the second month after the intervention. Method of measurement: Table of Specifications of Control and Tracking Cycles.;Duration of bleeding. Timepoint: Before the beginning of intervention - the first and the second month after the intervention. Method of measurement: Higam chart.;The severity of the bleeding. Timepoint: Before the beginning of intervention - the first and the second month after the intervention. Method of measurement: Higam chart.

—

Secondary

Measure	Time frame
Body Mass Index. Timepoint: Before the intervention, the first month and the second after the intervention. Method of measurement: Weight (kg) to square (m).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzie Zilae

Ahvaz University of Medical Sciences

Marziezilae67@gmail.com+98 61 3336 2414

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026